DFCI and BWH investigators show that lung cancers carrying a mutation in the gene EFGR respond to treatment with the drug Iressa, ushering in the era of precision oncology for solid organ cancers
DFCI and BWH investigators show that lung cancers carrying a mutation in the gene EFGR respond to treatment with the drug Iressa, ushering in the era of precision oncology for solid organ cancers